Debanjan Ray | CFO |
Sean McCarthy | President & CEO |
Mohit Bansal | Citigroup |
Christopher Marai | Nomura |
Biren Amin | Jefferies |
Boris Peaker | Cowen |
Mara Goldstein | Cantor Fitzgerald |
Robert Driscoll | Wedbush Securities |
Ying Huang | Bank of America, Merrill Lynch |
Good afternoon and Welcome to the CytomX 2017 Full Year Financial Results and Operational update. [Operator Instruction] Please be aware that today's conference call is being recorded. I'd now like to introduce the first speaker Debanjan Ray, CytomX Chief Financial Officer and Head of Corporate Development, you may begin.
Thank you, operator, good afternoon and thank you for joining us for our 2017 full year results review and operational update for CytomX Therapeutics.
Here with me today is CytomX's President and Chief Executive Officer, Dr.